Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.01 NZD
4.78 M NZD
650.53 M NZD
564.81 M
About RYMAN HEALTHCARE LIMITED NPV
Sector
Industry
CEO
Naomi James
Website
Headquarters
Christchurch
Founded
1984
ISIN
NZRYME0001S4
FIGI
BBG000BX7YP5
Ryman Healthcare Ltd. engages in the development and management of integrated retirement villages for the elderly. The firm offers services, apartments, rest homes, hospitals, and provides dementia and short-term care. It operates through the following geographical segments: New Zealand and Australia. The company was founded by John William Dudley Ryder and Kevin James Hickman in 1984 and is headquartered in Christchurch, New Zealand.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RYM is 4.94 NZD — it has increased by 0.41% in the past 24 hours. Watch RYMAN HEALTHCARE LIMITED NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NZX exchange RYMAN HEALTHCARE LIMITED NPV stocks are traded under the ticker RYM.
RYM stock has fallen by −1.40% compared to the previous week, the month change is a 6.47% rise, over the last year RYMAN HEALTHCARE LIMITED NPV has showed a −13.79% decrease.
We've gathered analysts' opinions on RYMAN HEALTHCARE LIMITED NPV future price: according to them, RYM price has a max estimate of 7.00 NZD and a min estimate of 5.03 NZD. Watch RYM chart and read a more detailed RYMAN HEALTHCARE LIMITED NPV stock forecast: see what analysts think of RYMAN HEALTHCARE LIMITED NPV and suggest that you do with its stocks.
RYM stock is 1.63% volatile and has beta coefficient of 1.38. Track RYMAN HEALTHCARE LIMITED NPV stock price on the chart and check out the list of the most volatile stocks — is RYMAN HEALTHCARE LIMITED NPV there?
Yes, you can track RYMAN HEALTHCARE LIMITED NPV financials in yearly and quarterly reports right on TradingView.
RYMAN HEALTHCARE LIMITED NPV is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
RYM net income for the last half-year is −181.91 M NZD, while the previous report showed 186.69 M NZD of net income which accounts for −197.44% change. Track more RYMAN HEALTHCARE LIMITED NPV financial stats to get the full picture.
RYMAN HEALTHCARE LIMITED NPV dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 1.58% and 16.61% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 7.70 K employees. See our rating of the largest employees — is RYMAN HEALTHCARE LIMITED NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RYMAN HEALTHCARE LIMITED NPV EBITDA is −1.35 M NZD, and current EBITDA margin is −0.21%. See more stats in RYMAN HEALTHCARE LIMITED NPV financial statements.
Like other stocks, RYM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RYMAN HEALTHCARE LIMITED NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RYMAN HEALTHCARE LIMITED NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RYMAN HEALTHCARE LIMITED NPV stock shows the sell signal. See more of RYMAN HEALTHCARE LIMITED NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.